Cargando…

A Novel RNA Transcript with Antiapoptotic Function Is Silenced in Fragile X Syndrome

Several genome-wide transcriptomics efforts have shown that a large percentage of the mammalian genome is transcribed into RNAs, however, only a small percentage (1–2%) of these RNAs is translated into proteins. Currently there is an intense interest in characterizing the function of the different c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khalil, Ahmad M., Faghihi, Mohammad Ali, Modarresi, Farzaneh, Brothers, Shaun P., Wahlestedt, Claes
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194623/ https://www.ncbi.nlm.nih.gov/pubmed/18213394 http://dx.doi.org/10.1371/journal.pone.0001486

Ejemplares similares

RNAi Screen Indicates Widespread Biological Function for Human Natural Antisense Transcripts
por: Faghihi, Mohammad Ali, et al.
Publicado: (2010)

Natural Antisense Inhibition Results in Transcriptional De-Repression and Gene Upregulation
por: Modarresi, Farzaneh, et al.
Publicado: (2012)

Knockdown of BACE1-AS Nonprotein-Coding Transcript Modulates Beta-Amyloid-Related Hippocampal Neurogenesis
por: Modarresi, Farzaneh, et al.
Publicado: (2011)

Screening for Small-Molecule Modulators of Long Noncoding RNA-Protein Interactions Using AlphaScreen
por: Pedram Fatemi, Roya, et al.
Publicado: (2015)

Evidence for natural antisense transcript-mediated inhibition of microRNA function
por: Faghihi, Mohammad Ali, et al.
Publicado: (2010)

RNA interference is not involved in natural antisense mediated regulation of gene expression in mammals
por: Faghihi, Mohammad Ali, et al.
Publicado: (2006)

Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome
por: Pastori, Chiara, et al.
Publicado: (2013)

Therapeutic potential of neuropeptide Y (NPY) receptor ligands
por: Brothers, Shaun P, et al.
Publicado: (2010)

A novel knockout mouse model of the noncoding antisense Brain-Derived Neurotrophic Factor (Bdnf) gene displays increased endogenous Bdnf protein and improved memory function following exercise
por: Modarresi, Farzaneh, et al.
Publicado: (2021)

Emerging treatment strategies for glioblastoma multiforme
por: Carlsson, Steven K, et al.
Publicado: (2014)

HDAC Inhibitors Induce BDNF Expression and Promote Neurite Outgrowth in Human Neural Progenitor Cells-Derived Neurons
por: Bagheri, Amir, et al.
Publicado: (2019)

Precision medicine in the treatment stratification of AML patients: challenges and progress
por: Lohse, Ines, et al.
Publicado: (2018)

Oxytocin and social functioning
por: Jones, Candace, et al.
Publicado: (2017)

Fragile X syndrome and fragile X-associated disorders
por: Rajaratnam, Akash, et al.
Publicado: (2017)

SIRT1 Inhibition Alleviates Gene Silencing in Fragile X Mental Retardation Syndrome
por: Biacsi, Rea, et al.
Publicado: (2008)

Histone Deacetylases Suppress CGG Repeat–Induced Neurodegeneration Via Transcriptional Silencing in Models of Fragile X Tremor Ataxia Syndrome
por: Todd, Peter K., et al.
Publicado: (2010)

The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer’s Disease
por: Magistri, Marco, et al.
Publicado: (2016)

Inhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model
por: Janczura, Karolina J., et al.
Publicado: (2018)

A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites
por: Du, Quan, et al.
Publicado: (2005)

A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites
por: Du, Quan, et al.
Publicado: (2005)

Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features
por: Baker, Emma K., et al.
Publicado: (2019)

Fragile X Syndrome
por: McLennan, Yingratana, et al.
Publicado: (2011)

Fragile X Syndrome
por: Saldarriaga, Wilmar, et al.
Publicado: (2014)

Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients
por: Dennison, Jessica L., et al.
Publicado: (2022)

Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL (TM))
por: Kemper, Christopher, et al.
Publicado: (2022)

A case report of novel mutation in PRF1 gene, which causes familial autosomal recessive hemophagocytic lymphohistiocytosis
por: Bordbar, Mohammad Reza, et al.
Publicado: (2017)

Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson’s Disease
por: Hossein-nezhad, Arash, et al.
Publicado: (2016)

Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome
por: Brasa, Sarah, et al.
Publicado: (2016)

Non-canonical DNA/RNA structures associated with the pathogenesis of Fragile X-associated tremor/ataxia syndrome and Fragile X syndrome
por: Yousuf, Aadil, et al.
Publicado: (2022)

Pharmacological Reactivation of the Silenced FMR1 Gene as a Targeted Therapeutic Approach for Fragile X Syndrome
por: Kumari, Daman, et al.
Publicado: (2019)

Splicing defect in FKBP10 gene causes autosomal recessive osteogenesis imperfecta disease: a case report
por: Maghami, Fatemeh, et al.
Publicado: (2018)

The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models
por: Aziz, Abdul Maruf Asif, et al.
Publicado: (2016)

Aging in fragile X syndrome
por: Utari, Agustini, et al.
Publicado: (2010)

Fragile X Syndrome in children
por: Acero-Garcés, David O., et al.
Publicado: (2023)

Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome
por: Berman, Robert F, et al.
Publicado: (2014)

R-loops Associated with Triplet Repeat Expansions Promote Gene Silencing in Friedreich Ataxia and Fragile X Syndrome
por: Groh, Matthias, et al.
Publicado: (2014)

BC RNA Mislocalization in the Fragile X Premutation
por: Muslimov, Ilham A., et al.
Publicado: (2018)

Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma
por: Lohse, Ines, et al.
Publicado: (2018)

DNA repair/replication transcripts are down regulated in patients with Fragile X Syndrome
por: Xu, Huichun, et al.
Publicado: (2013)

Antiapoptotic Molecule Survivin in Transplantation: Helpful or Harmful?
por: Assadiasl, Sara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fe473mc9gdmskjd629kk320an5